| 2022-11-03 | -65.1% | legal | SEC EDGAR | LUNG 8-K: 1.01 and 2.02 (SEC Filing) |
| 2025-07-31 | -46.9% | earnings | Seeking Alpha | Pulmonx slumps as Piper Sandler downgrades despite Q2 beat |
| 2025-07-31 | -46.9% | earnings | Seeking Alpha | Pulmonx revises 2025 revenue target to $90M–$92M as U.S. initiatives ramp slower, while international growth accelerates |
| 2025-07-31 | -46.9% | earnings | Seeking Alpha | Pulmonx Corporation (LUNG) Q2 2025 Earnings Call Transcript |
| 2025-07-31 | -46.9% | analyst | Investing.com | Piper Sandler downgrades Pulmonx stock to Neutral on growth concerns - Investing.com |
| 2026-03-05 | +42.1% | earnings | Moby | Pulmonx Corporation Q4 2025 Earnings Call Summary |
| 2026-03-05 | +42.1% | earnings | GuruFocus.com | Pulmonx Corp (LUNG) Q4 2025 Earnings Call Highlights: Strategic Restructuring and Sales Force ... |
| 2026-03-05 | +42.1% | earnings | MarketBeat | Pulmonx Q4 Earnings Call Highlights |
| 2026-03-05 | +42.1% | legal | SEC EDGAR | LUNG 8-K: 1.01, 1.02, 2.03, 3.02 (SEC Filing) |
| 2025-07-30 | -40.0% | earnings | Seeking Alpha | Pulmonx GAAP EPS of -$0.38 beats by $0.02, revenue of $23.86M beats by $0.39M |
| 2025-07-30 | -40.0% | legal | SEC EDGAR | LUNG 8-K: 2.02 (SEC Filing) |
| 2025-02-20 | +37.1% | news | Seeking Alpha | Pulmonx projects 16%-18% constant currency growth for 2025 with key initiatives scaling |
| 2025-02-20 | +37.1% | earnings | Seeking Alpha | Pulmonx Corporation (LUNG) Q4 2024 Earnings Call Transcript |
| 2025-04-30 | -29.2% | earnings | Seeking Alpha | Pulmonx GAAP EPS of -$0.36 beats by $0.04, revenue of $22.5M beats by $0.47M |
| 2025-04-30 | -29.2% | legal | SEC EDGAR | LUNG 8-K: 2.02 (SEC Filing) |
| 2024-02-22 | -27.6% | earnings | Seeking Alpha | Pulmonx Corporation 2023 Q4 - Results - Earnings Call Presentation |
| 2024-02-22 | -27.6% | earnings | Seeking Alpha | Pulmonx Corporation (LUNG) Q4 2023 Earnings Call Transcript |
| 2025-02-19 | +25.8% | earnings | Seeking Alpha | Pulmonx GAAP EPS of -$0.33 beats by $0.11, revenue of $23.8M beats by $1.51M |
| 2025-02-19 | +25.8% | legal | SEC EDGAR | LUNG 8-K: 2.02 (SEC Filing) |
| 2024-05-02 | +25.0% | earnings | Seeking Alpha | Pulmonx Corporation (LUNG) Q1 2024 Earnings Call Transcript |
| 2025-05-01 | -24.1% | news | Seeking Alpha | Pulmonx projects 20% long-term growth amid expanded initiatives and $12B market opportunity |
| 2025-05-01 | -24.1% | earnings | Seeking Alpha | Pulmonx Corporation (LUNG) Q1 2025 Earnings Call Transcript |
| 2025-05-01 | -24.1% | analyst | GuruFocus | Pulmonx (LUNG) Maintains "Buy" Rating with Stable Price Target | - GuruFocus |
| 2025-10-28 | +22.8% | earnings | Yahoo Finance | Pulmonx Corp (LUNG) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance |
| 2025-10-28 | +22.8% | analyst | Investing.com | Canaccord Genuity reiterates Buy rating on Pulmonx stock amid leadership changes - Investing.com |
| 2025-10-28 | +22.8% | earnings | StocksToTrade | LUNG’s Surprise Revenue Surge: Key Factors - StocksToTrade |
| 2025-10-28 | +22.8% | analyst | GuruFocus | Lake Street Lowers Price Target for Pulmonx (LUNG) Amidst Mainta - GuruFocus |
| 2024-05-01 | +22.7% | earnings | Seeking Alpha | Pulmonx GAAP EPS of -$0.36 |
| 2024-05-01 | +22.7% | legal | SEC EDGAR | LUNG 8-K: 2.02 (SEC Filing) |
| 2025-11-12 | -22.3% | earnings | Seeking Alpha | Pulmonx GAAP EPS of -$0.34 beats by $0.08, revenue of $21.5M beats by $0.6M |
| 2025-11-12 | -22.3% | legal | SEC EDGAR | LUNG 8-K: 2.02 (SEC Filing) |
| 2025-11-12 | -22.3% | earnings | Yahoo Finance | Pulmonx Corporation (LUNG) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance |
| 2025-11-13 | -22.3% | earnings | Seeking Alpha | Pulmonx outlines $89M–$90M 2025 guidance with renewed focus on execution and cost discipline |
| 2025-11-13 | -22.3% | earnings | Seeking Alpha | Pulmonx Corporation (LUNG) Q3 2025 Earnings Call Transcript |
| 2025-12-03 | +21.9% | executive | Investing.com | Pulmonx CEO French sells $13.8k in LUNG stock - Investing.com |
| 2025-12-03 | +21.9% | news | Stock Titan | Pulmonx (Nasdaq: LUNG) issues 1,625,000-share inducement grants, incl. 1.6M RSUs/PSUs - Stock Titan |
| 2023-02-22 | +20.4% | legal | SEC EDGAR | LUNG 8-K: 2.02, 2.03 (SEC Filing) |
| 2024-02-21 | -19.9% | earnings | Seeking Alpha | Pulmonx GAAP EPS of -$0.36 beats by $0.06, revenue of $19.27M beats by $1.03M |
| 2024-02-21 | -19.9% | legal | SEC EDGAR | LUNG 8-K: 2.02 (SEC Filing) |
| 2024-02-21 | -19.9% | legal | SEC EDGAR | LUNG 8-K: 5.02, 8.01 (SEC Filing) |
| 2025-10-27 | +19.3% | legal | SEC EDGAR | LUNG 8-K: 2.02, 5.02 (SEC Filing) |
| 2025-10-27 | +19.3% | earnings | Stock Titan | Pulmonx (Nasdaq: LUNG) reappoints Glen French as CEO; preliminary Q3 revenue ~$21.5M - Stock Titan |
| 2025-10-27 | +19.3% | earnings | Quiver Quantitative | Pulmonx Corporation Announces Leadership Transition and Preliminary Third Quarter 2025 Revenue Estimates - Quiver Quantitative |
| 2022-12-12 | +16.0% | analyst | eToro | Pulmonx Corporation (LUNG) Stock Price, News & Analyst Forecast - eToro |
| 2026-03-06 | +13.5% | legal | The Globe and Mail | Pulmonx Secures New Term Loan and Issues Warrants - The Globe and Mail |
| 2023-10-10 | -12.8% | legal | SEC EDGAR | LUNG 8-K: 2.02, 5.02, 7.01 (SEC Filing) |
| 2024-04-02 | -12.4% | executive | Seeking Alpha | Pulmonx appoints Mehul Joshi as CFO |
| 2024-04-02 | -12.4% | legal | SEC EDGAR | LUNG 8-K: 5.02, 8.01 (SEC Filing) |
| 2024-02-23 | -12.1% | analyst | Seeking Alpha | Pulmonx dips on Wells Fargo downgrade eyeing uncertainty over management changes |
| 2025-10-29 | -10.1% | earnings | Seeking Alpha | Pulmonx reports Q3 Preliminary results |
| 2024-05-23 | -9.8% | legal | SEC EDGAR | LUNG 8-K: 1.01 and (SEC Filing) |
| 2022-08-02 | +8.3% | legal | SEC EDGAR | LUNG 8-K: 2.02 and (SEC Filing) |
| 2024-07-31 | -8.3% | earnings | Seeking Alpha | Pulmonx GAAP EPS of -$0.39 |
| 2024-07-31 | -8.3% | legal | SEC EDGAR | LUNG 8-K: 2.02 (SEC Filing) |
| 2021-05-04 | -8.1% | legal | SEC EDGAR | LUNG 8-K: 2.02 and (SEC Filing) |
| 2026-04-07 | -7.7% | earnings | MarketBeat | Pulmonx (NASDAQ:LUNG) Stock Price Up 2.3% - Still a Buy? - MarketBeat |
| 2026-04-07 | -7.7% | earnings | MarketBeat | Pulmonx Corporation (NASDAQ:LUNG) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat |
| 2022-02-23 | -6.6% | legal | SEC EDGAR | LUNG 8-K: 2.02 and (SEC Filing) |
| 2024-10-31 | -6.1% | earnings | Seeking Alpha | Pulmonx Corporation (LUNG) Q3 2024 Earnings Call Transcript |
| 2021-11-02 | +6.1% | legal | SEC EDGAR | LUNG 8-K: 2.02 and (SEC Filing) |
| 2025-05-12 | -5.6% | news | Intellectia AI | LUNG Forecast — Price Prediction for 2026. Should I Buy LUNG? - Intellectia AI |
| 2024-10-30 | -5.4% | earnings | Seeking Alpha | Pulmonx GAAP EPS of $0.36 beats by $0.81, revenue of $20.4M beats by $0.12M |
| 2024-10-30 | -5.4% | legal | SEC EDGAR | LUNG 8-K: 2.02 (SEC Filing) |
| 2023-10-30 | +5.1% | legal | SEC EDGAR | LUNG 8-K: 2.02 (SEC Filing) |
| 2026-03-04 | +5.1% | earnings | Motley Fool | Pulmonx (LUNG) Q4 2025 Earnings Call Transcript |
| 2026-03-04 | +5.1% | earnings | Seeking Alpha | Pulmonx outlines 2026 revenue target of $90M-$92M with cost realignment and renewed U.S. sales focus |
| 2026-03-04 | +5.1% | earnings | Seeking Alpha | Pulmonx Corporation (LUNG) Q4 2025 Earnings Call Transcript |
| 2026-03-04 | +5.1% | earnings | Seeking Alpha | Pulmonx GAAP EPS of -$0.25 beats by $0.14, revenue of $22.59M beats by $0.86M |
| 2026-03-04 | +5.1% | legal | SEC EDGAR | LUNG 8-K: 2.02 (SEC Filing) |
| 2026-03-04 | +5.1% | earnings | Yahoo Finance | Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance |
| 2026-03-04 | +5.1% | news | Stock Titan | Lung device maker Pulmonx trims losses, guides 2026 sales to $90–92M - Stock Titan |
| 2026-03-04 | +5.1% | earnings | Benzinga | Earnings Summary: Pulmonx Q4 - Benzinga |
| 2026-02-18 | -4.9% | M&A | AD HOC NEWS | Pulmonx Stock Pops on Takeover Deal: Cash Exit or Hold Out? - AD HOC NEWS |
| 2026-03-31 | +4.8% | earnings | Zacks | TruBridge (TBRG) Beats Q4 Earnings Estimates |
| 2026-02-13 | +4.7% | news | AD HOC NEWS | Pulmonx Stock Under Pressure: Can A Niche Lung-Health Innovator Breathe New Life Into Its Shares? - AD HOC NEWS |
| 2026-02-20 | +4.5% | news | Stock Titan | Lung disease treatment firm Pulmonx sets March 4 date for 2025 results - Stock Titan |
| 2024-07-21 | +4.5% | earnings | Seeking Alpha | Pulmonx: Low Bar For Q2 Earnings |
| 2026-04-22 | -4.4% | news | Stock Titan | Executive pay and board votes at Pulmonx (NASDAQ: LUNG) 2026 meeting - Stock Titan |
| 2026-04-22 | -4.4% | legal | Stock Titan | [ARS] Pulmonx Corp SEC Filing - Stock Titan |
| 2024-08-01 | -4.3% | earnings | Seeking Alpha | Pulmonx Corporation (LUNG) Q2 2024 Earnings Call Transcript |
| 2026-04-17 | -3.7% | news | Zacks | Hims & Hers Health (HIMS) Soars 11.1%: Is Further Upside Left in the Stock? |
| 2026-04-17 | -3.7% | earnings | MarketBeat | Pulmonx Corporation (NASDAQ:LUNG) Short Interest Update - MarketBeat |
| 2025-10-31 | +3.5% | news | Yahoo Finance | Is Pulmonx Corporation (LUNG) One of the Best Stocks Under $3 to Invest In? - Yahoo Finance |
| 2026-04-16 | -3.5% | news | UBND thành phố Hải Phòng | Pulmonx Corporation (LUNG) Stock: Next Week (Selling Pressure) 2026-04-16 - Hedge Fund Favorites - UBND thành phố Hải Phòng |
| 2026-04-19 | -3.2% | news | Simply Wall St. | How The Pulmonx (LUNG) Investment Narrative Is Resetting Around A Lower Target And Execution Risk |
| 2023-05-02 | +2.9% | legal | SEC EDGAR | LUNG 8-K: 2.02 and (SEC Filing) |
| 2022-05-03 | -2.9% | legal | SEC EDGAR | LUNG 8-K: 2.02 and (SEC Filing) |
| 2026-03-27 | -2.8% | news | Stock Titan | Vanguard discloses zero Pulmonx holdings after internal realignment (NASDAQ: LUNG) - Stock Titan |
| 2022-02-25 | +2.8% | legal | SEC EDGAR | LUNG 8-K: 2.02 and (SEC Filing) |
| 2026-04-23 | -2.7% | earnings | Cổng thông tin điện tử tỉnh Tây Ninh | LUNG (Pulmonx Corporation) rises 5.63% on narrower Q4 2025 losses and steady 8% year over year revenue growth. - Crowd Sentiment Stocks - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-04-23 | -2.7% | earnings | UBND thành phố Hải Phòng | LUNG (Pulmonx Corporation) rises 5.63% on narrower Q4 2025 losses and steady 8% year over year revenue growth. - Management Guidance - UBND thành phố Hải Phòng |
| 2025-08-05 | -2.7% | news | Yahoo Finance | After Plunging 37.5% in 4 Weeks, Here's Why the Trend Might Reverse for Pulmonx (LUNG) - Yahoo Finance |
| 2026-01-10 | -2.6% | news | simplywall.st | Does Pulmonx (NASDAQ:LUNG) Have A Healthy Balance Sheet? - simplywall.st |
| 2025-06-05 | +2.4% | M&A | GuruFocus | Insider Buying: Daniel Florin Acquires Shares of Pulmonx Corp (L - GuruFocus |
| 2023-08-02 | -2.4% | legal | SEC EDGAR | LUNG 8-K: 2.02 (SEC Filing) |
| 2024-02-29 | -1.9% | news | Yahoo Finance | Steven Cohen's Point72 Asset Management Bolsters Position in Pulmonx Corp - Yahoo Finance |
| 2021-08-02 | -1.8% | legal | SEC EDGAR | LUNG 8-K: 5.02 (SEC Filing) |
| 2026-04-05 | +1.8% | earnings | Simply Wall St. | How The Pulmonx (LUNG) Investment Story Is Shifting After Q4 And New Guidance |
| 2026-04-05 | +1.8% | news | simplywall.st | Pulmonx Insiders Forfeit On 14% Gains After Selling Stock - simplywall.st |
| 2026-04-15 | +1.8% | news | GlobeNewswire | Pulmonx to Report First Quarter 2026 Financial Results on April 29, 2026 |
| 2026-04-15 | +1.8% | earnings | Stock Titan | Pulmonx sets April 29 earnings release, 4:30 p.m. ET webcast - Stock Titan |
| 2024-04-07 | +1.8% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2021-10-21 | -1.7% | earnings | Zacks Investment Research | What date does Pulmonx's (LUNG) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research |
| 2026-04-13 | +1.4% | news | AD HOC NEWS | Pulmonx Corp stock (US74586W1018): Is its airway treatment edge strong enough to unlock new upside? - AD HOC NEWS |
| 2024-03-26 | +1.4% | news | Seeking Alpha | Pulmonx: Revisiting Thesis Following Management Change |
| 2026-03-21 | +1.2% | news | Simply Wall St. | How The Pulmonx (LUNG) Narrative Is Resetting Around Execution Risks And Fair Value Assumptions |
| 2025-08-27 | -1.1% | news | Yahoo Finance | What Makes Pulmonx (LUNG) a New Buy Stock - Yahoo Finance |
| 2026-03-10 | -1.1% | earnings | Quiver Quantitative | Pulmonx Corporation (LUNG) Releases Q4 2025 Earnings: Revenue Down, Diluted Loss Per Share Widens - Quiver Quantitative |
| 2022-08-24 | +1.1% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Pulmonx (LUNG) - Zacks Investment Research |
| 2026-02-11 | -0.5% | news | simplywall.st | Pulmonx Corporation (NASDAQ:LUNG) Not Doing Enough For Some Investors As Its Shares Slump 29% - simplywall.st |
| 2021-08-03 | -0.2% | legal | SEC EDGAR | LUNG 8-K: 2.02 and (SEC Filing) |